Pharmaceutical Business review

Ehrfeld Mikrotechnik BTS, Lonza To Cooperate In Microreactor Technology

EMB will acquire a license from Lonza on two key products: the Lonza Development Microreactor (process development) and Lonza Advanced Production Microreactors (manufacturing). As a result, EMB will become the exclusive worldwide manufacturer, vendor and distributor of Lonza microreactors. Lonza microreactors are the advanced reactor technology for numerous chemical syntheses based on micro-structured devices.

Lonza and EMB also agree to further develop the product via the cooperation and development agreement.

Dominique Roberge, head of microreactor technology business development, said: “Both agreements are strategic for Lonza as they will broaden the base of users to freely utilize this cutting-edge reactor technology to develop the greener and sustainable processes of tomorrow. We are excited to continue to develop the Microreactor Technology and to strengthen the leading position of Lonza in this field.”

Olaf Stange, managing director of EMB, said: “This cooperation is an excellent strategic fit for us to extend our outstanding microreation technology portfolio with proven technology and know-how to serve our customers world wide. Together with Lonza and our key experts at Bayer Technology Services we are looking forward to becoming the leading supplier and consultant in the field of microreaction technology.”